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vs 31.28 years ± 4.59, ñ= 0.02), lower mean 
gestational age at delivery (35.72 weeks ± 3.16 vs 
38.49 weeks ± 2.1, ñ= 0.00). Variables with more low 
birth weight include <12years of schooling and being 
on mono/ dual therapy (31.8%). These differences 
were not statistically significant. 
On logistic regression, factors that retained an 
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ABSTRACT 
There remains uncertainty about the impact of HIV on pregnancy outcomes and effects of highly active 
antiretroviral therapy on fetal development. This study describes obstetric outcomes among HIV positive 
parturients at the University College Hospital, Ibadan. HIV positive parturients were identified in the birth 
register. During the 30-month period, 318 of 6203 deliveries were HIV positive (5.1%) with 97.6% record 
retrieval. The mean age of the HIV positive parturients was 31.66 years (± 4.66); the mean gestational age at 
delivery was 38.02 weeks (± 2.75) and the mean birth weight 2.85kg (±0.59). There were 35.8% (109) 
preterm births, 2.9% stillbirths and 21.5% low birth weights. The regimen most commonly (198, 64.5%) 
used was a non-nucleoside reverse transcriptase (NNRTI) based HAART. Preterm births were similar 
following spontaneous vaginal delivery (31.5%) and elective section (31%) but higher (41.3%) with 
emergency section (ñ=0.4). 
On univariate analysis, the preterm infants had lower mean birth weights (2.46±0.61 vs 2.96±0.44; ñ=0.000). 
The proportion of preterm births was higher among Low birth weight infants  (71.9% vs 28.1%; ñ=0.00). 
Variables with more preterm births were age >35 years (51.6%), ≤6years of schooling (51.5% vs 48.4%) and 
being on combination ARV (PI, 37.5% or non-PI, 36.2%). However, these differences did not attain 
statistical significance. Low birth weight infants had mothers who had higher mean ages (33.28 years ± 4.59 
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association with low birth weight were mean maternal age at delivery (ñ= 0.002; â= 0.904; 95% CI, 0.848 – 
0.966) and being on mono/ dual therapy (ñ= 0.039; â= 3.042; 95% CI, 1.055 – 8.768). The only factor that 
retained an association with preterm birth was mean maternal age at delivery (ñ= 0.015; â= 0.935; 95% CI, 
0.886 – 0.987). 
HIV positive (especially older) women, have high rates of preterm deliveries and low birth weights. The 
beneficial effects of HAART on mother-to-child transmission are indisputable but monitoring antiretroviral 
therapy in pregnancy remains a priority and antenatal surveillance should include fetal growth assessment.
INTRODUCTION 
12-14with these adverse pregnancy outcomes . 
The large number of HIV positive women who 
require PMTCT services and the uncertainty 
regarding the pattern of pregnancy outcomes 
among this group of parturients therefore 
necessitates the need for constant review. Thus, the 
objective of this study was to review the pregnancy 
outcomes – maternal and fetal – among HIV-
positive pregnant women who delivered at the 
labour ward of the University College of Hospital, 
Ibadan. 
METHODS
This retrospective cross-sectional study was 
conducted at the labour ward of the University 
College Hospital (UCH), Ibadan. The study period, 
over 30 months, was from January 2011 to June 
2013. The birth register was reviewed and the 
records of all women identified as HIV positive in 
this period were retrieved. Information that was 
obtained was as follows: selected socio-
demographic and neonatal characteristics, 
gestational age at delivery, mode of delivery etc.  
The University College Hospital Ibadan offers 
prevention of mother-to-child transmission 
(PMTCT) services in the Anti-retroviral Clinic 
supported by the AIDS Prevention Initiative in 
Nigeria (APIN) program and the President's 
Emergency Plan for AIDS Relief (PEPFAR) 
program. HIV positive pregnant women access 
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Nigeria, with a 4.1% HIV prevalence reported among 
pregnant women in the 2010 national sentinel survey, 
1contributes significantly to the global HIV burden . 
Because  women account for about 60% of the total 
HIV burden in Nigeria, the coexistence of HIV and 
1pregnancy is a common finding . The result is that 
315,00 to 625,00 children are delivered annually to 
HIV infected motehers in Nigeria, with an estimated 
63,000 to 125,000 infants acquiring acquiring HIV 
2from their mothers eah year . The result is that 
Nigeria contributes approximately 10% of the global 
burden of mother-to-child transmission of HIV 
3,4infection . 
5Some studies  have associated HIV in pregnancy 
with higher rates of adverse pregnancy outcomes 
such as stillbirths and low birth weight, while others 
6,7  have found no adverse effects of HIV infection on 
pregnancy outcome. In addition, while prevention of 
mother-to-child transmission of HIV (PMTCT) 
interventions can reduce the vertical transmission 
8rate of HIV to as low as 1 – 2%  and antiretroviral 
therapy (ART) provides clear benefits,  the evidence 
for the effect of highly active antiretroviral therapy 
(HAART) on adverse pregnancy outcomes is 
conflicting. While studies from Europe have 
provided support for an association between receipt 
of ART during pregnancy and an increased risk of 
9-11preterm birth (PTB) and low birth weight (LBW) , 
studies from the United States have not consistently 
associated maternal receipt of ART during pregnancy 
Trop J Obstet Gynaecol, 32 (1), April 2015
these services having being referred from the UCH 
antenatal clinic and other clinics in the environs. 
PMTCT services provided include opt-out system of 
HIV testing in pregnancy, antiretrovirals for PMTCT, 
infant feeding counseling and family planning 
counseling. In addition women are monitored by 
regular assay of CD4 count and viral load. Caesarean 
delivery is offered at no cost to the patient if there are 
obstetric indications or viral load above 1,000 copies 
per ml close to term (>36weeks gestational age).
Until April 2011, patients were either commenced on 
zidovudine (AZT) monotherapy or combination 
therapy of zidovudine and lamivudine (Combivir, 
CBV) for prophylaxis if CD4 count was more that 
200 cells per ml. Women with CD4 count less than 
200 cells per ml or symptomatic women with CD4 
200-249 cells /ml were commenced on the national 
first-line regimen of nevirapine (NVP)-based Highly 
Active Antiretroviral Therapy (HAART). 
Symptomatic women with CD4 count 250cells/ml 
ndand above or women on 2  line were placed on 
protease inhibitor (PI) based HAART therapy. 
Genotypic testing for antiretroviral resistance was 
not routinely available. After April 2011, all women 
were commenced on efavirenz based HAART 
following adoption of the WHO recommendations. 
Women on second line drugs were placed on PI based 
HAART. Approval was obtained from the joint UI/ 
UCH ethics committee. 
Statistical analysis was performed with the Statistical 
Package for Social Sciences (SPSS Inc, Chicago, Ill). 
Data was summarized with frequency tables and 
mean (± standard deviation). Information analysed 
included maternal demographic characteristics and 
antiretrivoral drug (ARV) type.  The pregnancy 
outcomes evaluated were LBW (<2500 g) and PD 
(gestational age <37completed weeks).Chi-square 
2(÷ ) test was used for analysis of categorical 
variables. Continuous variables were analyzed using 
student's T-test or analysis of variance (ANOVA) for 
groups more than two. Signi?cance was de?ned as ñ 
value <.05. These variables were examined within 
two groups divided by birth weight (<2500 g and ≥
2500 g) or gestational age (<38 weeks and ≥37 
weeks) for statistical significance by Logistic 
regression analysis. Multivariate Logistic 
regression analysis was used to explore the 
potential risk factors for LBW/PD. All variables in 
the univariate analysis with P value <0.25 and those 
deemed clinically significant were entered into 
multivariate models using stepwise logistic 
regression. Variables were held in the models if they 
reached a significance level of P <0.05.
RESULTS
During the study period, there were 6203 deliveries. 
Three hundred and eighteen women (318) were 
HIV positive giving a prevalence of 5.1%. Of these 
307 casenotes were retrieved giving a retrieval rate 
of 97.6%. Fifty- four of the women were unbooked 
in UCH, being newly discovered to be HIV positive 
in labor.  The mean age of all the parturients was 
31.66 years (± 4.66), while the mean gestational age 
at delivery was 38.02 weeks (± 2.75). The mean 
birth weight was 2.85kg (±0.59).
Over half (214, 69.7%) of the patients were in the 
age range 26 to 35 years ( see table 1). While most 
(236, 76.9%) had at least 12 years of education only 
2 patients reported being single. Although, over half 
(190, 61.2%) of the patients presented at term, the 
prevalence of preterm delivery was 35.8% (109). 
Elective cesarean section was the mode of delivery 
in 27.4% (84) of the patients.  The drug regimen 
most commonly (198, 64.5%) used by the 
parturients was a non-nucleoside reverse 
transcriptase (NNRTI) based HAART. 
The gestational age at delivery following 
spontaneous vaginal delivery compared to 
deliveries after caesarean section showed a similar 
proportion of preterm deliveries; 31.5% after 
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vaginal delivery and 31% after elective cesarean 
delivery (see table 2). In contrast women who had 
emergency delivery had more preterm deliveries 
(41.3%). These differences were however not 
statistically significant (ñ=0.4). Review of neonatal 
characteristics revealed a male sex preponderance of 
54.7% (see table 3). There were 2.9% stillbirths and 
21.5% low birth weights. 
Over a third (35.8%) of the infants were born preterm 
(see figure 1). Table 4 shows the factors that were 
associated with preterm delivery. The mean birth 
weight of the preterm infants was lower (2.46±0.61 
vs 2.96±0.44). The difference was statistically 
significant (ñ=0.000). The mean age of the mothers 
with preterm babies was higher. Compared to the 
other age groups, mothers older than 35 years had a 
higher proportion of preterm infants (51.6%). 
Women with six years or less of schooling also had 
higher proportion of preterm deliveries (51.5% vs 
48.4%). Other factors that demonstrated higher 
proportion of preterm infants include having 
emergency CS (42.1%), being low birth weight 
(71.9% vs 28.1%) and being on combination ARV 
(PI, 37.5% or non-PI, 36.2%). However, only being 
low birth weight achieved statistical significance. 
The differences observed in the other factors did not 
attain statistical significance.
Table 5 shows the factors that were associated with 
low birth weight. The mean age of the mothers with 
low birth weight babies was higher (33.28 years ± 
4.59 vs 31.28 years ± 4.59, ñ= 0.02) . The mean 
gestational age at delivery was also lower ( 35.72 
weeks ± 3.16 vs 38.49 weeks ± 2.1, ñ= 0.00 ). These 
differences were statistically significant. Mothers 
older than 35 years had a higher proportion of low 
birth weight infants (35.9%). Women with twelve 
years or more of schooling had lower proportion of 
low birth weight infants. Other factors that 
demonstrated higher proportion of low birth weight 
infants include being preterm (42.6%) or being on 
mono/ dual therapy (31.8%). However, the factors 
that were statistically significant were the age of the 
mother and preterm birth.
On logistic regression the factors that retained an 
association with low birth weight were mean 
maternal age at delivery (ñ= 0.002; â= 0.904; 95% 
CI, 0.848 – 0.966) and being on mono/ dual therapy 
(ñ= 0.039; â= 3.042; 95% CI, 1.055 – 8.768) while 
the factor that retained an association with preterm 
birth was only mean maternal age at delivery (ñ= 
0.015; â= 0.935; 95% CI, 0.886 – 0.987).
DISCUSSIONS
The mean age of the parturients was 31.66 years ( ± 
4.66). This is similar to the mean age of 30.1 years 
(±5.1) reported by van der Merwe et al from South 
15Africa . Majority (78.8%) of the women were in 
the age group 20-34years, similar to the values 
reported by Ezechi et al from Lagos (84.7%) and 
1,8Onah et al in Enugu, (72.6%) both in Nigeria . HIV 
infection in this relatively younger age group has a 
negative impact on the economy, especially in 
developing countries. This is on account of this 
group being sizeable in the workforce.
The overall preterm delivery rate of 35.8% in this 
cohort of HIV positive women is much higher than 
1the rate of 11.1% reported by Ezechi et al , 13.5% 
16by Townsend et al working in England and 13.6% 
17by Taguebue et al who worked in Cameroon . All 
of these worked with groups of HIV positive 
women. Mokuolu et al reported a rate of 11.8% 
among the general obstetric population in a 
18teaching hospital in Southern Nigeria . In Europe 
and the US, studies in the general obstetric 
populations have reported preterm delivery rates of 
19-21 18,225-10%  and 12.5%  respectively.  In our cohort 
of HIV positive women, only older maternal age at 
delivery and being low birth weight were found to 
be statistically significant in their association with 
preterm delivery. The finding of maternal age being 
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associated with preterm delivery in this study is 
23contrary to the findings of Ezechi et al  and Szyld et 
24al.  who found no association between maternal age 
and preterm delivery in the groups of HIV positive 
women they studied. However, it has been noted that 
pregnancy in the parturient of advanced age is 
associated with significant increase in maternal and 
25fetal risk . This is on account of their demonstrating 
an increased rate of pre-gestational chronic medical 
complications such as type 2- diabetes mellitus and 
25-29chronic hypertension. .  
Although some concordance exists between birth 
weight and gestational age, they are not 
interchangeable. Only around two thirds of low birth 
30weight infants are preterm . Term infants maybe of 
low birth weight because they are 'small for 
gestational age' or 'light for date' infants. Preterm 
infants may also be small for gestational age. Thus, 
they may have neonatal problems additional to those 
related to shortened gestation, particularly if they are 
30small because of intrauterine growth restriction . In 
this cohort of HIV positive women, of the 190 term 
infants 28.1% were LBW while of the LBW infants 
9.6% were delivered at term.
There was a higher proportion of preterm birth 
among women with fewer years of education, 
although this did not attain statistical significance. 
Different variables including occupation, type of 
housing and years of education have been used by 
31-different authors as proxy socioeconomic variables 
33. Level of education maybe used as a proxy for 
socioeconomic status. Poor economic background of 
the mother has been described as one of the most 
important predictors of spontaneous preterm 
30delivery . The interaction of many factors that 
contribute to the association of preterm birth with 
socioeconomic status has been described as being 
complex. For example mothers who smoke 
cigarettes are twice as likely as non-smoking mothers 
to deliver before 32 weeks of gestation. However, 
while antenatal smoking cessation programs can 
lower the incidence of preterm birth, other 
interactions such as better antenatal care, dietary 
advice or increased social support during pregnancy 
have not been shown to improve perinatal outcomes 
or reduce the social inequalities in the incidence of 
30preterm delivery .       
Patients on combination HAART demonstrated 
higher preponderance of preterm births. This, 
however, did not achieve statistical significance. 
The effect of antiretroviral therapy on prevalence of 
preterm birth among HIV positive women remains 
unclear with con? icting data from various research 
settings. While some demonstrated increased risk of 
1,9,15,16preterm delivery with antiretrovirals  others 
24,34demonstrated no such increase . The workers 
who demonstrated an association between 
antiretrovirals and preterm delivery have reported 
this association with the initiation of combination 
therapy before pregnancy or during the first 
1,9,15,35,36trimester of pregnancy . 
Various reasons have been proffered for the 
association of preterm births with HIV and 
16,37antiretrovirals . One of them is the Th2 to Th1 
cytokine shift  associated with HAART 
administration. Successful pregnancies are 
characterised by an increase in Th2 cytokines and 
suppression of Th1 cytokine production, a Th1 to 
37Th2 cytokine shift . A similar shift is also observed 
in the disease progression of HIV infection. Fiore et 
al (2006) hypothesised that the increased risk of 
premature delivery reported in HIV-infected, 
HAART-treated pregnant women is mediated 
through changes in the cytokine environment in 
37pregnancy . They investigated the levels of 
interleukin IL-2 (Th1) and IL-10 (Th2) in 
peripheral blood mononuclear cells (PBMCs) 49 
HIV-infected women. They were able to 
demonstrate favourable immunomodulation 
induced by HAART with increased IL-2 (Th1) and 
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decreased IL-10 (Th2). They showed that each unit 
increase in IL-2-PHA slope was associated with an 
8% increased risk of premature delivery (AOR, 1.08; 
95% CI, 1.0-1.17; p=0.005). They concluded that 
HAART use in pregnancy while providing 
significant benefits in delaying HIV disease 
progression and reducing the risk of mother-to-child-
transmission, may however be counterproductive in 
terms of successful pregnancy outcome.
It must however be noted that preterm birth may also 
be associated with a multitude of factors that include 
family and psychosocial histories. For example, 
other factors reported by Ezechi et al in their group of 
HIV positive women include multiple pregnancies, 
stressful work, and presence of opportunistic 
1infection at delivery . Of particular interest in this 
cohort is the stratification of gestational age at 
delivery by mode of delivery. The rate of preterm 
delivery among women delivering per vaginam was 
similar to those delivered by elective cesarean 
delivery. Women delivered by emergency cesarean 
section however had a higher rate of preterm 
delivery. Women delivering per vaginam having 
opted for this mode of delivery antenatally are 
probably a better reflection of the true prevalence of 
preterm delivery among HIV +ve women. The 
prevalence of preterm delivery in this group was 
35.5% which is still quite higher than the rate 
reported in the general obstetric population by 
18Mokuolu et al . Other studies do not perform these 
stratifications often including all births no matter the 
mode of delivery. 
The prevalence of low birth weight in this group of 
HIV positive women was 21.5%. This is higher than 
the rates of 9.4% and 13.0% reported respectively by 
23 36Ezechi et al  and Haeri et al . However, it is similar 
to the rates of 19.6% and 22.4% reported respectively 
15 34by van der merwe et al  and Yu et al . All four 
groups worked with HIV positive pregnant women. 
The conference of Paediatric Association of Nigeria 
(PANCORF) has reported a LBW prevalence of 
3814% in the general Nigerian obstetric population . 
Ahmadu et al. working in Maiduguri reported a 
33prevalence of 12.9% LBW , while Ugboma and 
39Onyearugha reported a prevalence of 8.3% . The 
latter two groups also worked with the general 
obstetric population. 
Only older maternal age at delivery and being 
preterm were found to be statistically significant in 
their association with LBW. Links between rising 
maternal age and LBW especially among blacks 
33,39,40have been reported . Possible reasons for this 
include the fact that mothers at this age may have 
less physiologic reserve compared to younger 
mothers. This is because older mothers are more 
likely to be multiparous which has a depleting effect 
33on their nutrient store . In addition, as previously 
noted, this group of mothers are likely to have 
25pregestational chronic medical illnesses . 
As previously stated, the level of education of the 
mothers was used as proxy for socioeconomic class 
(SEC) with lower class being associated with fewer 
years of education. Women with more years of 
education had a lower proportion of LBW. It has 
been suggested that the effect of low SEC factors 
start at the time of conception through low 
physiologic reserves, inadequate medical care, poor 
33,41,42diet and high risk of infectious diseases . In 
addition, women with more years of education 
could be exposed to information on the importance 
of prenatal health care coupled with personal and 
environmental cleanliness, which has been found to 
33,41reduce the toll of infectious disease . Promoting 
these practices among women, including HIV +ve 
women, may lower the possibility of mothers giving 
41birth to LBW babies .   
Interestingly, women on mono/dual therapy had 
higher proportion of low birth weight infants. This 
is in spite of their having fewer preterm infants. 
Various studies have attempted to evaluate the 
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effect of maternal ART regimens on adverse infant 
outcome such as LBW. While some workers have 
demonstrated increased odds of LBW among HIV 
16,36+ve women on HAART  others have found no 
association between HAART and LBW, no matter 
9,24,34the treatment group . A possible explanation for 
the increased odds of LBW among HIV positive 
women on HAART maybe found in the effect of 
HAART on preeclampsia. An association between 
HAART and an increased risk of pre-eclampsia has 
43-45been observed , and the association of 
hypertension and pre-eclampsia with increased risks 
46,47of preterm birth and LBW is well recognized . 
We must caution that our study is an overall 
evaluation of perinatal outcomes in HIV positive 
parturients. Our retrospective study design precluded 
an optimal assessment of medication compliance 
within this population. In addition, no data was 
collected on duration of receipt of ART prior to 
pregnancy. In addition, preterm birth has been 
associated with a multitude of factors that include 
family and psychosocial histories for which we could 
not account. Despite these limitations, we conclude 
that HIV positive women who use HAART may be at 
increased risk for preterm birth and low birth weight. 
Antenatal surveillance in HIV positive mothers 
should therefore include serial fetal growth 
assessment by USS. An HIV-infected woman of 
child bearing age is in the unique position of making 
treatment decisions which will not only impact on her 
48,49own health, but may also affect her future children  
(1, 8). Thus health care providers need to discuss 
future plans with HIV positive women when 
deciding what kind of antiretroviral therapy to 
initiate.
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Table 1: Characteristics Of HIV Positive Mothers 
Delivered At UCH Ibadan
Maternal Characteristic Frequency ( 307) Percentage (100.0 %)  
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Mode of delivery 
 
Vaginal del. 
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   Table 2: Gestational age at delivery by mode of delivery














9 (8.3%) ÷- 8.405
34-37  29 (26.1%)  25 (29.8%)  36 ( 33.0%)








Mean GA at delivery 38.01(± 2.99) 38.8 (± 1.52) 37.51(± 2.82) ñ=0.153
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Table 3: Characteristics of Infants Delivered To HIV 
Positive Mothers at UCH Ibadan
Neonatal Characteristic Frequency ( 307) Percentage (100.0 %)  
Sex of neonate 
Male 168 54.7%
Female 137 44.6%
Not stated 2 0.7% 
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Low birth weight 66 21.5%
Not LBW 236 76.8%
Not stated 5 1.6%
Table 4: Factors Associated With Preterm Birth
Preterm (N=110) Not Preterm(N=190) 95% CI 
p-value
Maternal Characteristic
Mean maternal age (years) 32.61±5.09 31.19±4.32 +0.323 to -2.517 0.089
Mean birth weight (kg) 2.48±0.61 2.96± 0.44 -0.596 to -0.354 0.000
Age of mother Preterm Not Preterm ÷2 p-value































Primary/ none 17, 51.5%  16, 48.5%  
Others 9, 36%   16, 64.0%  
Mode of delivery 



























Birth weight at delivery
LBW 46, 71.9% 18, 28.1% 44.128 0.00
Not LBW 62, 26.7% 170, 73.3%
Drug type 
Mono/ dual 5, 25.0% 15, 75.0% 1.064 0.587
NonNNRTI 71, 36.2% 125, 63.8%
PI-based 12, 37.5% 20, 62.5%
Table 5: Factors Associated With Low B irth Weight ( LBW)
LBW (N= 66) Not LBW (236) 95% CI  p-value
Maternal Characteristic
Mean maternal age (years) 33.28±4.59 31.28±4.59 +0.729 to +3.28    0.02
Mean gest. Age at del. (weeks) 35.78±3.16 38.49±2.10 -3.365 to -2.047    0.000
Age of mother LBW Not LBW ÷2 p-value



































Others 7, 28.0%  18, 72.0%  
Mode of delivery 



























Gestational age at delivery
 
Preterm 46, 42.6% 62, 57.4% 44.128 0.00
Not LBW 18, 9.6% 170, 90.4%
Drug type 
Mono/ dual 5, 31.8% 15, 68.2% 1.557 0.459
NonNNRTI 42, 21.4% 154, 78.6%
PI-based 6, 18.2% 27, 81.8%
Table 6 Predictors Of LBW And Preterm Delivery
Predictors of LBW
Educational level signif exp (â) 95% CI lower  upper
Tertiary 0.638 - - -
Secondary 0.155 2.844 0.672 12.32 
Primary 0.232 2.314 0.584 0.168 

















Gest. Age at delivery





































































































Vaginal delivery 0.427 - - -
ELCS 0.347 1.311 0.746 2.305 
EMCS 0.222 1.491 0.785 2. 831
Drug type
NonNNRTI 0.834 - - -
M/D 0.563 0.725 0.244 2.156
PI 0.646 0.739 0.204 2. 681
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